Tissue Engineering And Nanotheranostics

b2815 Tissue Engineering and Nanotheranostics “9.61x6.69”

276 Tissue Engineering and Nanotheranostics

252. Pawar H, Surapaneni SK, Tikoo K, Singh C, Burman R, Gill MS, Suresh
     S. Folic acid functionalized long­circulating co­encapsulated docetaxel
     and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacoki­
     netic and biodistribution in rats. Drug Deliv. 23 , 1453–1468 (2016).


253. Liu Y, Li K, Pan J, Liu B, Feng SS. Folic acid conjugated nanoparticles
     of mixed lipid monolayer shell and biodegradable polymer core for
     targeted delivery of Docetaxel. Biomaterials 31 , 330–338 (2010).


254. Lin JJ, Chen JS, Huang SJ, Ko JH, Wang YM, Chen TL, Wang LF.
     Folic acid­Pluronic F127 magnetic nanoparticle clusters for combined
     targeting, diagnosis, and therapy applications. Biomaterials 30 , 5114–
     5124 (2009).


255. Liu J, Kolar C, Lawson TA, Gmeiner WH. Targeted drug delivery to
     chemoresistant cells: Folic acid derivatization of FdUMP[10]. enhances
     cytotoxicity toward 5­FU­resistant human colorectal tumor cells. J. Org.
     Chem. 66 , 5655–5663 (2001).


256. Low PS, Henne WA, Doorneweerd DD. Discovery and development
     of folic­acid­based receptor targeting for imaging and therapy of cancer
     and inflammatory diseases. Acc. Chem. Res. 41 , 120–129 (2008).


257. Cheng C, Wei H, Zhu JL, Chang C, Cheng H, Li C, Cheng SX,
     Zhang XZ, Zhuo RX. Functionalized thermoresponsive micelles self­
     assembled from biotin­PEG­b­P(NIPAAm­co­HMAAm)­b­PMMA
     for tumor cell target. Bioconjugate Chem. 19 , 1194–1201 (2008).


258. Yang W, Cheng Y, Xu T, Wang X, Wen LP. Targeting cancer cells with
     biotin­dendrimer conjugates. Eur. J. Med. Chem. 44 , 862–868 (2009).


259. Maiti S, Park N, Han JH, Jeon HM, Lee JH, Bhuniya S, Kang C, Kim
     JS. Gemcitabine­coumarin­biotin conjugates: A target specific thera­
     nostic anticancer prodrug. J. Am. Chem. Soc. 135 , 4567–4572 (2013).


260. Wang Y, Wang X, Zhang Y, Yang S, Wang J, Zhang X, Zhang Q.
     RGD­modified polymeric micelles as potential carriers for targeted
     delivery to integrin­overexpressing tumor vasculature and tumor cells.
     J. Drug Target. 17 , 459–467 (2009).


261. Fani M, Mueller A, Tamma ML, Nicolas G, Rink HR, Cescato R,
     Reubi JC, Maecke HR. Radiolabeled bicyclic somatostatin­based ana­
     logs: a novel class of potential radiotracers for SPECT/PET of neu­
     roendocrine tumors. J. Nuc. Med. 51 , 1771–1779 (2010).


262. Iyer AK, Singh A, Ganta S, Amiji MM. Role of integrated cancer nano­
     medicine in overcoming drug resistance. Adv. Drug Deliv. Rev. 65 ,
     1784–1802 (2013).